Blood Transfusion Devices Market, By Product Type (Pathogen Reduction System, Apheresis Devices, Blood Component Separator, Blood Bag & Accessory, Venous Access Devices, Others (Filters, Blood Mixer, Fridge & Freezer)), By End User (Hospital, Ambulatory S

Blood Transfusion Devices Market, By Product Type (Pathogen Reduction System, Apheresis Devices, Blood Component Separator, Blood Bag & Accessory, Venous Access Devices, Others (Filters, Blood Mixer, Fridge & Freezer)), By End User (Hospital, Ambulatory Surgical Centers, Blood Bank, Others (Research & Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Blood Transfusion Devices Market, By Product Type (Pathogen Reduction System, Apheresis Devices, Blood Component Separator, Blood Bag & Accessory, Venous Access Devices, Others (Filters, Blood Mixer, Fridge & Freezer)), By End User (Hospital, Ambulatory Surgical Centers, Blood Bank, Others (Research & Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Blood transfusion is a frequent procedure in which donated blood or blood components are administered to patients via an intravenous (IV) line. Blood transfusion is used to replenish blood and blood components that have been depleted. This potentially life-saving operation can assist in replacing blood lost due to surgery or injury. Blood transfusion can also help if an ailment stops the body from producing blood or some of its components properly. Transfusions provides necessary part or parts of blood, with red blood cells being the most usually transfused. Whole blood, which contains all of the components is also given to patients in need, however whole blood transfusions are uncommon. Blood transfusions are typically administered in hospitals, outpatient clinics, or at the doctor's office. The treatment normally takes one to four hours, depending on the parts of the blood received and the amount of blood required. Apheresis systems, infusion devices, blood warmers, venous access devices, and filters are some of the blood transfusion devices.

Market Dynamics

Non-profit health systems are providing blood carrying services at emergency medical vehicles to provide better medical services to patients in need. For instance, on April 19, 2023, BannerAir, a U.S.-based hospital-based air medical transport program, started carrying blood on its hospital-based air ambulance helicopters to improve outcomes for patients in dire medical situations. This potentially life-saving service was made possible by Banner Health's collaboration with Laboratory Sciences of Arizona (LSA), a subsidiary of Banner Health, that oversees its laboratories. It plays a critical role in the treatment of patients suffering from massive blood loss due to trauma or other injuries. Such services are anticipated to boost demand for blood transfusion devices at such rapid medical vehicles.

Key features of the study:

• This report provides an in-depth analysis of the global blood transfusion devices market and provides market size (US$ Bn ) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blood transfusion devices market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Ecomed Solutions, LLC., Kaneka Corporation, Immucor Inc., Haemonetics Corporation, Becton Dickinson and Company, RAYS S.P.A., Baxter, Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, Vitestro, and 3M Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global blood transfusion devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood transfusion devices market

Global Blood Transfusion Devices Market Detailed Segmentation:

• By Product Type:
• Pathogen Reduction System
• Apheresis Devices
• Blood Component Separator
• Blood Bag & Accessory
• Venous Access Devices
• Others
• By End User:
• Hospital
• Ambulatory Surgical Centers
• Blood Bank
• Others
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Fresenius Kabi AG
• Grifols, S.A.
• Tenko International Group Corp
• Terumo Corporation
• Kawasumi Laboratories Inc.
• Ecomed Solutions LLC.
• Kaneka Corporation
• Immucor Inc.
• Haemonetics Corporation
• Becton Dickinson and Company
• RAYS S.P.A.
• Baxter
• Macopharma SA
• B. Braun Melsungen AG
• Baxter International Inc.
• Neomedic Limited
• Vitestro
• 3M Company